Home・Список акций・Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corp

Закрыт

СекторЗдравоохранение

17.05 -3.51

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

16.98

Макс.

17.6

Ключевые показатели
By Trading Economics
Доход	9.2M 4.6M
Продажи	27M 419M
Прибыль на акцию	0.56
Рентабельность продаж	1.103
Сотрудники	4,427
EBITDA	-35M 28M

Рекомендации
By TipRanks
Рекомендации	Нейтрально
Прогноз на 12 месяцев	+9.11% upside

Дивиденды
By Acuity
Следующий отчет о доходах	29 окт. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-129M 1.4B
Предыдущая цена открытия	20.56
Предыдущая цена закрытия	17.05

Новостные настроения

By Acuity

25%

75%

72 / 340 Рейтинг в Healthcare

Integra LifeSciences Holdings Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

6 авг. 2026 г., 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Wednesday's close. The stock remains below its 20-day moving average.

5 авг. 2026 г., 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains significantly below its 20-day moving average.

4 авг. 2026 г., 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Tuesday's session, approximately 3.60% below the 20-day moving average, with no specific news identified.

3 авг. 2026 г., 20:51 UTC

Integra Lifesciences Holdings Corp gains in after-market hours, reflecting broader market optimism despite no specific company news. Major indices also show significant increases.

31 июл. 2026 г., 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Friday's session, trading near the lower end of their one-month range with no specific news identified.

30 июл. 2026 г., 17:41 UTC

Integra Lifesciences Holdings Corp shares are higher today, despite earlier session pullbacks. No specific news was identified to explain the movement.

29 июл. 2026 г., 21:01 UTC

Integra Lifesciences shares are lower in after-market hours, reflecting a broader decline in U.S. equities amid rising oil prices and geopolitical tensions.

28 июл. 2026 г., 20:03 UTC

News

Shares of Integra Lifesciences Holdings are higher, supported by UBS's Neutral rating and price target of $19 amid broader Health Care Equipment gains.

27 июл. 2026 г., 19:51 UTC

Integra Lifesciences Holdings Corp shares are lower today amid notable volatility, despite remaining near the upper end of their one-month trading range.

24 июл. 2026 г., 19:02 UTC

News

Integra Lifesciences shares are higher today, following a downgrade from Wall Street Zen and a price target increase from Truist Financial to $19.00.

21 июл. 2026 г., 18:46 UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

20 июл. 2026 г., 19:26 UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Сравнение c конкурентами

Изменение цены

Integra LifeSciences Holdings Corp Прогноз

Целевая цена

By TipRanks

9.11% рост

Прогноз на 12 месяцев

Средняя 19.29 USD 9.11%

Максимум 25 USD

Минимум 17 USD

Основано на мнении 9 аналитиков Wall Street, спрогнозировавших целевые цены для Integra LifeSciences Holdings Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

9 ratings

Покупка

Удержание

Продажа

Основано на мнении 9 аналитиков, присваивавших рейтинги акциям Integra LifeSciences Holdings Corp – Данные за последние 3 месяца.

Настроения

By Acuity

72 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.